Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVENUE THERAPEUTICS, INC.ATXI · Entity 8537 | 10% owner | December 11, 2023 | December 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVENUE THERAPEUTICS, INC.
Report date December 11, 2023 · Filed December 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 681,000 |
Reported balance
After 2023-12-11 transaction · row 1
1 source rowRow 1 · 2023-12-11 · Sale · Disposed 264,000 · Balance 681,000 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. |
| Common StockSEC Table I · non-derivative | IndirectJoint account with spouse | 22,000 |
Reported balance
After 2023-12-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-12-11 · Sale · Disposed 18,000 · Balance 22,000 F2: Consists of shares of common stock held in a joint account with the Reporting Person's wife. |
| Common StockSEC Table I · non-derivative | IndirectTrustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust | 74,000 |
Reported balance
After 2023-12-11 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-12-11 · Sale · Disposed 61,000 · Balance 74,000 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3: Consists of shares of common stock held in trusts for the benefit of the Reporting Person's children in which the Reporting Person is the trustee. |
| Common StockSEC Table I · non-derivative | IndirectShared investment and voting authority | 215,800 |
Reported balance
After 2023-12-11 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2023-12-11 · Sale · Disposed 126,000 · Balance 215,800 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F4: Consists of shares of common stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared voting and dispositive authority. |
| Common StockSEC Table I · non-derivative | IndirectShared investment authority | 147,000 |
Reported balance
After 2023-12-11 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2023-12-11 · Sale · Disposed 128,000 · Balance 147,000 F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F5: Consists of shares of commons stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared dispositive authority. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 80,000 |
Reported balance
After 2023-12-11 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2023-12-11 · Sale · Disposed 20,000 · Balance 80,000 F6: Consists of shares of common stock held by the Reporting Person's wife. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F2: Consists of shares of common stock held in a joint account with the Reporting Person's wife.
F3: Consists of shares of common stock held in trusts for the benefit of the Reporting Person's children in which the Reporting Person is the trustee.
F4: Consists of shares of common stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared voting and dispositive authority.
F5: Consists of shares of commons stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared dispositive authority.
F6: Consists of shares of common stock held by the Reporting Person's wife.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 20,000 | $0.14 | $2,800.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 6 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 80,000 F6 · ownership.nature: Consists of shares of common stock held by the Reporting Person's wife. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 128,000 | $0.14 | $17,920.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 5 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Shared investment authority Disclosed balance after: 147,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F5 · ownership.nature: Consists of shares of commons stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared dispositive authority. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 126,000 | $0.14 | $17,640.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 4 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Shared investment and voting authority Disclosed balance after: 215,800 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F4 · ownership.nature: Consists of shares of common stock held in accounts maintained for the benefit of certain individuals or trusts over which the Reporting Person has shared voting and dispositive authority. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 61,000 | $0.14 | $8,540.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 3 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust Disclosed balance after: 74,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · ownership.nature: Consists of shares of common stock held in trusts for the benefit of the Reporting Person's children in which the Reporting Person is the trustee. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 18,000 | $0.15 | $2,700.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 2 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Joint account with spouse Disclosed balance after: 22,000 F2 · ownership.nature: Consists of shares of common stock held in a joint account with the Reporting Person's wife. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 16:02 UTC | AVENUE THERAPEUTICS, INC. ATXI · Entity 8537 | SaleCommon Stock | 264,000 | $0.14 | $36,960.00 |
DisclosureSEC source: 0001553350-23-000471 · davidow.xml · nonDerivative · entry 1 Davidow Robert L · CIK 0002002210 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 681,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.